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Heterochromatin plays a central role in the process
of immune evasion, pathogenesis, and transmission
of the malaria parasite Plasmodium falciparum
during blood stage infection. Here, we use ChIP
sequencing to demonstrate that sporozoites from
mosquito salivary glands expand heterochromatin
at subtelomeric regions to silence blood-stage-
specific genes. Our data also revealed that hetero-
chromatin enrichment is predictive of the transcrip-
tion status of clonally variant genes members that
mediate cytoadhesion in blood stage parasites. A
specific member (here called NF54varsporo) of the
var gene family remains euchromatic, and the resul-
tant PfEMP1 (NF54_SpzPfEMP1) is expressed at
the sporozoite surface. NF54_SpzPfEMP1-specific
antibodies efficiently block hepatocyte infection
in a strain-specific manner. Furthermore, human
volunteers immunized with infective sporozoites
developed antibodies against NF54_SpzPfEMP1.
Overall, we show that the epigenetic signature of
var genes is reset in mosquito stages. Moreover,
the identification of a strain-specific sporozoite
PfEMP1 is highly relevant for vaccine design based
on sporozoites.Cell R
This is an open access article under the CC BY-NINTRODUCTION
The most devastating form of human malaria is caused by the
protozoan parasite P. falciparum, with more than 200 million
people infected annually and an estimated 445,000 deaths in
2017 (World Health Organization, 2017). Malaria is transmitted
by the bite of an infected Anopheles mosquito, which harbors
sporozoites in its salivary glands. From the point of injection
into the skin, sporozoites migrate via blood vessels to the liver,
cross the sinusoidal cell layer separating the blood and the liver,
and finally invade hepatocytes where asexual reproduction leads
to the release of thousands of merozoites into the bloodstream
(Prude^ncio and Mota, 2007). Merozoites infect mature red blood
cells and, through asexual reproduction, generate daughter
merozoites to initiate a new infective cycle. The persistence
and pathogenesis of P. falciparum during blood stage prolifera-
tion relies on the exclusive and successive expression of variant
surface adhesion molecules, PfEMP1, expressed at the mem-
branes of infected red blood cells (iRBCs) and mediate cytoad-
hesion in the microvasculature (Smith, 2014). This immune
evasion mechanism, termed ‘‘antigenic variation,’’ depends on
monoallelic expression of one of approximately 60 var genes
that encode PfEMP1 proteins.
Different epigenetic factors lead to the default transcriptional
silencing of all but one var gene via the establishment of facultative
heterochromatin (Guizetti and Scherf, 2013). Heterochromatin
protein 1 (PfHP1) is a key regulator of facultative heterochromatin
in P. falciparum (Flueck et al., 2009; Pe´rez-Toledo et al., 2009),eports 22, 2951–2963, March 13, 2018 ª 2018 The Author(s). 2951
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Chromosome Ends and Heterochromatin Islands Cluster at the Nuclear Periphery in P. falciparum Sporozoites
(A) DNA fluorescence in situ hybridization (FISH) of telomere distribution in sporozoites using a probe (magenta) against sub-telomeric repeat TARE6 (top) and
corresponding quantification of the number of TARE6 foci per nucleus (bottom).
(B) Immunofluorescence of PfHP1 (green) in sporozoites using anti-PfHP1 antibodies (top) and corresponding quantification of the number of PfHP1 foci per
nucleus (bottom).
For (A) and (B), error bars represent the 95% confidence intervals (±SEM) established for 50 sporozoites from three independent experiments.
(C) Combined DNA FISH of telomere distribution (using a TARE6 probe in magenta) and immunofluorescence of PfHP1 distribution (green) using anti-PfHP1
antibodies in sporozoites (top) and corresponding quantification of the percent overlap of TARE6 and PfHP1 foci per nucleus (bottom). Co, colocalized;
Adj, adjacent; Non-Co, non-colocalized. Error bars represent SD from two independent experiments.
For (A)–(C), DNA was stained with DAPI (blue), and the wide-field (WF) image is merged with the fluorescent images. Scale bars, 5 mm.and conditional depletion of PfHP1 disrupts transcriptional
repression of var genes as well as the master regulator of sexual
commitment, PfAP2-G (Brancucci et al., 2014). In addition,
transcription of a single var gene is associated with antisense
transcription of a long non-coding RNA (lncRNA) originating
from its intron, a conserved feature shared by all members of
the var family (Ralph et al., 2005; Jiang et al., 2013; Amit-Avraham
et al., 2015). Thus, the parasite uses multiple layers of epigenetic
regulation to ensure monoallelic expression of variant gene fam-
ilies, which creates phenotypic plasticity in genetically identical
parasites during blood stage development (Lopez-Rubio et al.,
2009; Rovira-Graells et al., 2012).
Although variegated gene expression appears to have evolved
as a survival strategy to promote prolonged blood stage infec-
tions in humans, it is unknown whether heterochromatin-
mediated control of variant gene families is important in other
parasite stages, such as the sporozoite stage. Sporozoites
have been successfully used to provide immune protection to
human volunteers and are a key stage to target for malaria
vaccine development (Richie et al., 2015).
To study the organization of heterochromatin in sporozoites,
which are relatively low in abundance in the mosquito salivary
glands, we developed a robust, low-cell-input chromatin
immunoprecipitation followed by massively parallel sequencing
(ChIP-seq) protocol. ChIP-seq of PfHP1 revealed a remarkable
organization of heterochromatin in sporozoites that differs from2952 Cell Reports 22, 2951–2963, March 13, 2018that observed in asexual blood stage parasites. Furthermore,
our epigenetic analysis predicted the expression of a specific
PfEMP1 on the surface of sporozoites. Antibodies raised against
this particular PfEMP1 efficiently blocked sporozoite infection of
human hepatocytes in a strain-specific manner, demonstrating a
previously unknown role of the var gene family in malaria parasite
transmission.
RESULTS
Heterochromatin Islands Form Nuclear Clusters in
Sporozoites
In P. falciparum blood stage parasites, the maintenance of
heterochromatin islands is linked to the physical tethering of
these genomic regions to the nuclear periphery, forming 4–7
perinuclear foci (Lopez-Rubio et al., 2009). PfHP1 is a major
component of heterochromatin in perinuclear chromosome
clusters. To determine whether a similar spatial chromosome
arrangement exists in sporozoites, we performed DNA fluores-
cence in situ hybridization (FISH) using a probe corresponding
to the conserved sub-telomeric repeat TARE6 (Telomere-
Associated Repeat 6) (Figure 1A) and indirect immunofluores-
cene assays (IFAs) with antibodies against PfHP1 (Figure 1B).
We observed an average of 2–4 TARE6-containing foci per
nucleus, which localized to the nuclear periphery and overlap-
ped with PfHP1-containing foci (Figure 1C). These data indicate
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Figure 2. Genome-wide Distribution of Eu- and Heterochromatin in P. falciparum Sporozoites
(A) Circos plot of ChIP-seq data showing genome-wide enrichment of PfHP1 (red), H3K9me3 (blue), and H3K9ac (green) in sporozoites. Coverage plots
are represented as average reads per million (RPM) over bins of 1,000 nt with a maximum y axis value of 400 for PfHP1, 500 for H3K9me3, and 400 for H3K9Ac.
The 14 chromosomes are represented by the outer gray circle, with chromosome sizes given in megabases (Input, black). Statistical analysis of the biological
replicates is presented in Table S1. MACS2-based peak calling analysis of PfHP1, H3K9me3, and H3K9ac enrichment in sporozoites is presented in Table S2.
(B) PfHP1, H3K9me3, and H3K9Ac enrichment across chromosome 7 in sporozoites, with genomic position indicated at the top in kilobases. Coverage plots are
represented as average RPM over bins of 1,000 nt, with the maximum value of y axis indicated.
Data are representative of three or more independent experiments. See also Tables S1 and S2.a conserved spatial organization of heterochromatin in the
nucleus between asexual blood stage parasites and salivary
gland sporozoites.
PfHP1 Genome-wide Distribution in P. falciparum
Sporozoites
Previous studies have used ChIP to elucidate the role of histone
post-translational modifications (PTMs), histone variants, and
other chromatin factors in gene expression during the asexual
stage of the human malaria parasite, P. falciparum (Lopez-Rubio
et al., 2013). In asexual blood stages, PfHP1 andH3K9me3 regu-
late transcription of clonally variant virulence gene families such
as var by establishing facultative heterochromatin at promoter
regions and gene bodies (Lopez-Rubio et al., 2009; Flueck
et al., 2009). These heterochromatic regions span approximately
100 kb, forming so-called heterochromatin islands at sub-
telomeric regions and several internal chromosome clusters.
Because the number of sporozoites that can be recovered
from the infected mosquito salivary gland is low, we developed
a robust low input ChIP-seq protocol, which allowed us to use
approximately 600,000–800,000 sporozoites per immunopre-
cipitation (IP). We investigated the genome-wide distribution of
heterochromatin by performing ChIP with highly specific anti-
bodies against PfHP1 and the transcriptionally repressive his-
tone H3 modification lysine 9 trimethylation (H3K9me3) (Tables
S1 and S2). We observed an enrichment of PfHP1 and
H3K9me3 in sub-telomeric regions of all 14 chromosomes, as
well as in central chromosome regions of chromosomes 4, 6,
7, 8, and 12 (Figure 2A; Table S2). These regions contain variantgene families and show a similar heterochromatin enrichment
in blood stage parasites (Lopez-Rubio et al., 2009). In contrast,
ChIP-seq of the transcriptionally activating mark H3K9ac
revealed its absence from these heterochromatic loci and
enrichment within chromosome regions that primarily contain
housekeeping genes (Figures 2A and 2B). Notably, ApiAP2-G,
a member of the AP2 DNA-binding protein family that is involved
in gametocyte formation, appears to be enriched in PfHP1 and
H3K9me3 in sporozoites as it is in asexual blood stage parasites,
suggesting a re-setting of the chromatin of this gene after
gametogenesis is complete (Figure S1). We conclude that the
heterochromatin organization is largely preserved in different
life cycle stages.
Heterochromatin Spreads into Genes Coding for
Exported Blood Stage Proteins in Sporozoites
When comparing the genome-wide PfHP1 pattern in sporozoites
to that in asexual blood stage parasites (Figure 3A), we observed
an overall similar organization of PfHP1 islands along all 14 chro-
mosomes. We noted, however, a significant sporozoite-specific
spreading of sub-telomeric heterochromatin from nearly all chro-
mosome ends toward central chromosomal regions (Figures 3A
and 3B). These extended heterochromatic regions of approxi-
mately 50 kb are highly enriched in genes encoding parasite pro-
teins that are typically exported to the host erythrocyte during
blood stage development, remodeling the erythrocyte to accom-
modate the parasite’s needs (de Koning-Ward et al., 2016) (Fig-
ures 3B and S2). RNA sequencing in sporozoites showed that
steady-state mRNA levels of these subtelomeric genes encodingCell Reports 22, 2951–2963, March 13, 2018 2953
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Figure 3. Heterochromatin Islands at Chromosome Ends Are Extended in P. falciparum Sporozoites Relative to Blood Stages
(A) Circos plot of ChIP-seq data compares genome-wide PfHP1 enrichment in sporozoites (spz; red lines) and asexual blood stage parasites (ring; gray lines).
Coverage plots are represented as average RPM over bins of 1,000 nt with a y-axis maximum value of 400 for PfHP1 in sporozoites and 1,500 for PfHP1 in blood
stages. The 14 chromosomes are represented by the outer gray circle, with chromosome sizes given inmegabases. Statistical analysis of the biological replicates
is presented in Table S1. MACS2-based peak calling analysis of PfHP1, H3K9me3, and H3K9ac enrichment in sporozoites is presented in Table S2.
(B) An enlarged view of a 149-kb sub-telomeric region of the right arm of chromosome 7 shows PfHP1 enrichment in the genomes of sporozoites (spz; red) and
blood stage parasites (ring; black). Genes encoding exported proteins of iRBCs are highlighted in orange below the plot. Coverage plots are represented as
average RPM over bins of 1 nt, with the maximum value indicated on the y axis.
Data are representative of three or more independent experiments. See also Tables S1 and S2.blood-stage-exported proteins have an inverse correlation
with H3K9me3/HP1 occupancy (Figure S3; Table S3), linking
sporozoite heterochromatin extension to stage-specific gene
silencing.
Heterochromatin Enrichment Predicts Expression of a
var Gene in Sporozoites
In asexual blood stage parasites, a single PfEMP1 is expressed
at any given time on the erythrocyte surface, and this expression
correlates with low levels of PfHP1 and H3K9me3 within the pro-
moter and gene body of the corresponding var gene. In contrast,
the silent var genes are enriched for these heterochromatic
marks (Lopez-Rubio et al., 2009). We performed MACS2-based
peak enrichment analysis of four independent PfHP1 (Tables
S2A and S4A) and three independent H3K9me3 (Table S2B)
ChIP-seq sporozoite experiments. All var genes present in
the NF54 P. falciparum strain were enriched for PfHP1 and
H3K9me3 (Table S4A, ‘‘Peaks’’). Intriguingly, one var gene
(PF3D7_0809100) consistently showed the lowest enrichment
of PfHP1 within its promoter and gene body (Figure 4A;
Table S4A), suggesting that the corresponding PfEMP1 may
be expressed in sporozoites. PF3D7_0809100 (subsequently
referred to as NF54varsporo) is located in the central region of
chromosome 8, adjacent to two other var genes and two mem-
bers of a second clonally variant gene family rif, all of which retain
higher levels of PfHP1 and H3K9me3 (Figure 4A). In general,
other clonally variant gene families, including rif, Pfmc2TM,
and PfACS, which are located proximal to sub-telomeric
var genes on 13 of the 14 chromosomes, appear to maintain2954 Cell Reports 22, 2951–2963, March 13, 2018blood-stage-like heterochromatin patterns: only two of 180 rif
genes, one of 13 Pfmc2TM genes, and five of 13 PfACS genes
are depleted for PfHP1 and H3K9me3 (Table S5).
Given the major role of PfEMP1 in parasite virulence and
immune evasion (Wahlgren et al., 2017), we focused on the
expression of var genes in sporozoites. We investigated
NF54varsporo transcription by performing strand-specific RNA
sequencing (RNA-seq) analysis of the sporozoite steady-state
transcriptome (Figure S4; Table S3). As shown in Figure 4B
(lower panel) and Figure 4C, we did not detect full-length
mRNA transcripts for NF54varsporo in the sporozoite (Tables
S4B and S4C), but only bidirectional intronic promoter activity
(Figure 4C, left panel) similar to that observed for silent var genes
in the late-stage asexual blood stage parasites (Ralph et al.,
2005; Epp et al., 2009). Despite identifying low-level, full-length
mRNAs for two other var genes, PF3D7_0711700 and
PF3D7_0412400 (Figure 4B, bottom panel; Figure S5; Tables
S4B and S4C), these lack antisense noncoding RNAs (ncRNAs)
to exon I that has been associated with var gene transcriptional
activation and monoellelic expression in asexual blood stage
parasites (Figure S5, left panel; and Table S4D) (Ralph et al.,
2005; Jiang et al., 2013; Amit-Avraham et al., 2015). For this
reason, we consider that var genes PF3D7_0711700 and
PF3D7_0412400 may not be expressed in the sporozoite stage.
Since var mRNA transcription and PfEMP1 expression show
limited overlap during asexual blood stage development, it is
possible that NF54varsporo is transcribed at the stage that pre-
cedes sporozoites: the oocysts in the mosquito midgut. Indeed,
RNA-seq of oocysts (day 8 post-infection of the mosquito)
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Figure 4. PfHP1 Occupancy Predicts Transcription of NF54varsporo in Sporozoites
(A) ChIP sequencing data show enrichment of PfHP1 (red) and H3K9me3 (blue) over a 55-kb genomic region of chromosome 8 (chromosome coordinates are
shown at top) in P. falciparum sporozoites. The coverage of the ChIP input DNA is indicated in black, and the MACS2-based peaks (Table S2) are indicated as
rectangular boxes underneath the coverage plots. Coverage plots are represented as averageRPMover bins of 1,000 nt with themaximum value indicated on the
y axis. Data are representative of three or more independent experiments. The var gene PF3D7_0809100, or NF54varsporo, shows low H3K9me3/PfHP1
enrichment and is highlighted in green.
(B) RNA-seq shows var gene transcription across differentP. falciparum life-cycle stages: asexual-ring-stage parasites 12 hr post-invasion (two replicates at top),
mosquito-derived oocysts (three replicates in the middle), and mosquito salivary gland sporozoites (three replicates at bottom). Transcripts corresponding to
(legend continued on next page)
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revealed the presence of the full-length transcript of
NF54varsporo, which showed the highest RPKM (reads per
kilobase of exon model per million reads) value of any var gene
in three biological replicates (Figures 4B, middle panel, and
4C, right panel; Tables S4B and S4C), indicating that
NF54_SpzPfEMP1 could be synthesized already in late mos-
quito stages. We observed another full-length var transcript,
PF3D7_1240600; however, in the absence of intron-derived
exon I antisense ncRNA, we speculate that this prohibits protein
expression (Figure S5, right panel; Tables S4C and S4D).
Alternatively, the observed oocyst var transcripts are expressed
in individual parasites. Sporozoites expressing NF54varsporomay
have a selective advantage in the process of migration to the
salivary gland, leading to, predominantly, sporozoites that
express NF54_SpzPfEMP1.
In contrast, RNA-seq data from the parental ring asexual
blood stage parasites detected almost no reads mapping to
NF54varsporo compared to the predominantly transcribed var
gene, PF3D7_1200600 (top panel of Figure 4B; Tables S4B
and S4C), suggesting a reset of var gene transcription during
the parasite transmission stage.
AStrain-Specific PfEMP1 Is Expressed on the Surface of
Sporozoites
To determine whether the PfEMP1 protein encoded by
NF54varsporo is synthesized in sporozoites, we prepared NF54
sporozoite extracts and performed immunoblotting assays using
either an antibody against the conserved intracellular C-terminal
ATS (Acid Terminal Segment) domain that reacts with all PfEMP1
proteins (Nacer et al., 2015) or specific antibodies against the
extracellular variable domain of NF54_SpzPfEMP1 (Figure 5A).
Anti-NF54_SpzPfEMP1 antibodies and the anti-ATS reacted
with a band corresponding to the predicted molecular weight
of NF54_SpzPfEMP1 (241 kDa in Figures 5B and S6A). These
sera detect smaller bands of approximately 70 to 75 KDa that
may represent degraded forms of PfEMP1. Furthermore, IFAs
of fixed NF54 sporozoites using mouse anti-NF54_SpzPfEMP1
and ATS antibodies showed a surface membrane-like staining
pattern (Figure 5D). Almost all sporozoites (>98%) react with
the anti-NF54_SpzPfEMP1 antibodies. We observed a similar
IFA staining pattern in six independent NF54 sporozoite prepara-
tions, supporting the selective expression of a member of the
var gene family. No surface staining was observed with anti-
bodies against the extracellular domain of the PfEMP1 encoded
by var2CSA (Pf3D7_1200600) or the CIDR (cysteine-rich
interdomain region) domain of an unrelated central var gene
(Pf3D7_0412700), both of which retain H3K9me3/PfHP1 enrich-
ment in sporozoites (Figure S6B; data not shown).
Since NF54varsporo is not conserved in other P. falciparum
parasite strains (http://www.plasmodb.org) we performed IFAexon I of each var gene (shown on the x axis) are indicated as RPKM (reads per kil
transcription was only considered when above the red dotted line. See Table S4
(C) Each var gene has two exons that flank a conserved intron. Shown in the top pa
from silent and active var genes. The bottom panel shows stranded RNA-seq d
oocysts (right). Coverage plots of steady-state RNA levels are indicated as RPKM (
reads for sense (green) and antisense (red) transcription shown below the corres
See also Table S4.
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Cambodian clone NF135 (Teirlinck et al., 2013). NF135 reacts
with antibodies directed against the major surface antigen of
sporozoites, Circumsporozoite protein (CSP) (Figure 5C). How-
ever, no cross-reactivity with anti-NF54_SpzPfEMP1 was
observed. Expression of a PfEMP1 was confirmed by using
anti-ATS (Figure 5D). These data suggest that an antigenically
variant PfEMP1 antigen, possibly with a similar function as that
of NF54_SpzPfEMP1, is expressed on the surface of NF135
P. falciparum sporozoites. Moreover, we performed blastp on
the NF135 proteome (UniProt ID: UP000019114, based on the
assembly deposited at GenBank [GEO: AOPS00000000], Broad
Institute). No ortholog of NF54varsporo was detectable in NF135,
supporting the hypothesis that anti- NF54_SpzPfEMP1 anti-
bodies do not crossreact with NF135 sporozoites.
The IFAs on live sporozoites, with intact cell membranes, and
the anti-NF54_SpzPfEMP1 antibody, but not the anti-ATS
antibody, stained the surface of sporozoites (Figure 5E). Trypsin
treatment of live sporozoites (50 mg/mL) abolished antibody
surface reactivity in immunofluorescence and by western blot,
confirming that the CIDR domain of NF54_SpzPfEMP1 is extra-
cellular in sporozoites (Figures 5B and 5E). Together, these
results provide evidence of expression of a clonally variant and
strain-specific PfEMP1 protein at the surface of sporozoites
with a similar orientation to that seen at the membrane of iRBCs.
To study further the specificity of the anti-NF54_SpzPfEMP1,
we incubated NF54 asexual blood stage parasites, with
magnetic beads coated with immunoglobulin G (IgG) of anti-
NF54_SpzPfEMP1. After three rounds of selection, we obtained
parasites that react (>30%) with anti-NF54_SpzPfEMP1 (Fig-
ure S6C). qRT-PCR analysis on RNA prepared from ring stage
parasites before and after panning showed an enrichment for
NF54varsporo transcripts of approximately 50-fold (Figure S6D).
We demonstrate that the same PfEMP1 can be expressed in
two distinct phases of the life cycle.
Antibodies against NF54_SpzPfEMP1 Block Sporozoite
Infection of Hepatocytes
In intra-erythrocytic parasites, PfEMP1 proteins are exported
across the parasite membrane and the parasitophorous
vacuolar membrane to the surface of the erythrocyte, where
they serve as adhesion molecules that can bind to a variety of
endothelial receptors such as CD36, ICAM, etc., causing malaria
pathogenesis by obstructing blood vessels in critical organs
such as the brain (Wahlgren et al., 2017). Antibodies against
the extracellular PfEMP1 region have been shown to block the
rosetting phenotype and/or adhesion to various host endothelial
receptors, such as CD36 or CSA.
Because NF54_SpzPfEMP1 is expressed on the surface of
mature sporozoites, we evaluated its potential to interact withobase of exon per one million mapped reads), indicated on the y axis. var gene
for more details.
nel are schematics representing transcription of varmRNAand intronic ncRNAs
ata that demonstrate NF54varsporo gene transcription in sporozoites (left) and
reads per kilobase of exon per onemillionmapped reads), with themapped raw
ponding coverage plot.
A B
C
D
E
Figure 5. NF54_SpzPfEMP1 Protein Is Strain Specific and Exported to the Sporozoite Surface
(A) Schematic representation of the predicted domains of the PfEMP1 encoded by PF3D7_0809100 and the corresponding antibodies against the semi-
conserved ATS region and the polymorphic domains of the NF54_SpzPfEMP1.
(legend continued on next page)
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hepatocytes, thus contributing to hepatocyte infection. We pre-
incubated freshly isolated salivary gland sporozoites with either
the anti-NF54_SpzPfEMP1 mouse antibody (both serum and
the purified IgG) against the first 737 amino acids containing
the DBL1 and CIDR1 domains (Figure 5A) or the corresponding
pre-immune serum before adding the sporozoites to a primary
human hepatocyte culture. After 3 days of infection, we
observed that the anti-NF54_SpzPfEMP1 serum strongly
reduced hepatocyte infection in a dilution-dependent manner,
whereas the preimmune mouse serum showed only very low
inhibition (Figure 6A). It is noteworthy that the purified anti-
NF54_SpzPfEMP1 IgG (1.8 mg/mL) inhibits hepatocyte infection
at a level similar to that of the anti-CSP IgG (20 mg/mL)
(Figure 6A). Importantly, anti-NF54_SpzPfEMP1 did not
block infection with clone NF135, which does not express
NF54_SpzPfEMP1 (Figures 5D and 6A), whereas the anti-CSP
antibody blocked both strains at levels >90% (Figure 6A).
Lastly, we assessed the immunogenicity of NF54_SpzPfEMP1
during natural infection. Serum of volunteers infected with NF54
sporozoites under chloroquine cover was obtained from a previ-
ous clinical trial that demonstrated that protective responses
were mainly directed against P. falciparum pre-erythrocytic
stages (Roestenberg et al., 2009) and was able to inhibit sporo-
zoite invasion into hepatocytes (Peng et al., 2016). HEK293 cells
expressing NF54_SpzPfEMP1, SEA-1 (PF3D7_1021800, posi-
tive control), or Etramp 14.2 (PF3D7_1476100, negative control)
were incubated with serum and then subjected to fluorescence-
assisted cell sorting. As shown in Figures 6B and 6C, the serum
of one third of the infected volunteers contained significant anti-
body levels against NF54_SpzPfEMP1 (N-terminal CIDR region
from amino acids 1–737), indicating that this PfEMP1 molecule
is exposed on the surface of P. falciparum parasites before para-
site blood stage infection develops.
DISCUSSION
Epigenetic regulation of var gene transcription and studies on the
role of PfEMP1 in malaria pathogenesis have been focused on
blood stage parasites (Guizetti and Scherf, 2013; Smith et al.,
2013). Here, we present highly reproducible data from multiple
NF54 sporozoite preparations that a specific member of the
var multigene family (60 members) is expressed in mosquito
salivary gland parasites. Although we found that the overall
nuclear organization is surprisingly conserved between asexual
blood stage parasites and migratory sporozoite stages of
P. falciparum, our developed ChIP-seq protocol for salivary
gland stage sporozoites uncovered several features that provide
insight into the biology of malaria transmission to humans.
A striking feature is that subtelomeric heterochromatic region(B) Western blot analysis of sporozoite extracts using anti-ATS or anti-NF54_Spz
protein extraction. Molecular weights are shown at the left of the blot, and PfEM
(C) Immunofluorescence analysis of fixed sporozoites of two different strains (NF
(D) Immunofluorescence analysis of fixed and permeabilized sporozoites of two di
(green) and anti-ATS (red) antibodies.
(E) Surface immunofluorescence of live sporozoites (top) and live sporozoites afte
(red) antibodies.
For (C)–(E), DNA was stained with DAPI (blue), and the wide-field (WF) image is s
2958 Cell Reports 22, 2951–2963, March 13, 2018extends to genes that are exported into the host cell in asexual
stages, adding a new parasite strategy to silence genes that
are not used in free-living stages.
Our genome-wide analysis of PfHP1 and H3K9me3 enrich-
ment predicted the expression of a member of the var gene
family: Pf3D7_0809100 or NF54varsporo. Given that a bulk culture
of the NF54 blood stage parasites express var genes that are
distinct from NF54varsporo, we propose that an epigenetic reset-
ting of var genes occurs during mosquito stage development to
select for expression of a specific PfEMP1 on the surface of
sporozoites. We detect the NF54varsporo transcript in late oocyst
stage parasites, but this does not exclude the possibility that the
resetting occurs at an earlier transmission stage. Regardless of
when the epigenetic resetting occurs, our data suggest that,
similar to asexual blood stage parasites, sporozoites may main-
tain monoallelic expression of var genes.
Our observation of epigenetic resetting of var genes is
supported by transcriptional data obtained from blood stage
parasites after passage through the mosquito. Studies with hu-
man volunteers have shown that var gene choice is altered
upon mosquito transmission (Bachmann et al., 2016). A recent
study reported the presence of a specific var gene transcript in
sporozoites obtained from P. falciparum-infected patients from
a malaria-endemic region in Africa; however, the authors did
not report whether the corresponding PfEMP1 was produced
(Go´mez-Dı´az et al., 2017). In light of these published data and
our results, genetically different parasite strains may express
antigenically variant PfEMP1 proteins in sporozoites.
Thus far, the biological role of the PfEMP1 surface adhesion
molecule was believed to be restricted to immune evasion in
the asexual blood stage. Our IFA data show that all salivary
gland sporozoites express NF54_SpzPfEMP1 on their surface
in a manner similar to that of iRBCs. It is currently unclear
why a particular var gene member would be specifically
targeted for mosquito stage expression. Structural analysis of
NF54_SpzPfEMP1 does not reveal any specific features that
would make it a particularly good candidate for expression at
the sporozoite plasma membrane. One possibility is that the
expression of a particular adhesive property may enhance
sporozoite migration and hepatocyte infection. This hypothesis
may limit the choice of expressed var gene for efficient trans-
mission of parasites. The NF54varsporo gene has not been stud-
ied before, and its adhesive features remain unknown.
Given that all asexual blood stage PfEMP1 proteins studied so
far display adhesive properties (Smith, 2014), we hypothesized
that NF54_SpzPfEMP1 plays a role in sporozoite interaction
with various host tissues and infection of hepatocytes. Indeed,
antibodies directed against the DBL and CIDR domains of
NF54_SpzPfEMP1 resulted in very potent inhibition of hepatocytePfEMP1 antibodies. Anti-PfAldolase antibodies served as a positive control for
P1 is indicated with an arrow.
54 at top and NF135 on bottom) using anti-CSP antibodies (green).
fferent strains (NF54 at top andNF135 on bottom) using anti-NF54_SpzPfEMP1
r trypsin treatment (bottom) using anti-CSP (green) and anti-NF54_SpzPfEMP1
hown at the right. Scale bars, 5 mm.
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Figure 6. Antibodies against NF54_
SpzPfEMP1 Inhibit Sporozoite Infection
of Primary Human Hepatocytes
(A) NF54_SpzPfEMP1 antibody inhibition of he-
patocyte infection of NF54 sporozoites expressing
NF54_SpzPfEMP1 (black) and of NF135 sporo-
zoites that did not express NF54_SpzPfEMP1
(gray). Data are presented as the percentage of
inhibition over the untreated control after treat-
ment with the following antibodies: anti-CSP, anti-
NF54_SpzPfEMP1 immune serum, or the corre-
sponding anti-NF54_SpzPfEMP1 pre-immune
serum or purified IgG. Data represent the average
of two independent biological experiments.
*p < 0.0205, as measured using a two-way
ANOVA. Error bars indicate SD.
(B and C) Detection of antibodies against
NF54_SpzPfEMP1 in sera isolated from
individuals immunized with infective bites and
non-infective bites under chloroquine (CQ) pro-
phylaxis. The sera were used to label HEK293 cells
expressing NF54_SpzPfEMP1, schizont egress
antigen (PfSEA; positive control), or Etramp14.2
(negative control), which were analyzed by flow
cytometry. A second negative control used
NF54_SpzPfEMP1 pre-immune sera to probe
HEK293 cells expressing NF54_SpzPfEMP1.
(B) An anti-IgM (immunoglobulin M)-FITC
(fluorescein isothiocyanate) signal (x axis) in-
dicates specific binding, and a propidium iodide
(PI) signal (y axis) indicates dead cells. Gate 3
consists of cells positive for IgM staining for either
NF54_SpzPfEMP1, PfSEA, or Etramp.
(C) Quantification of the serum IgG (black) or IgM
(gray) response from all individuals in the chloro-
quine sera set as measured by fluorescence-
activated cell sorting (FACS). Individual volunteers
are shown on the x axis, and the mean of three
technical replicates of serum response is shown
on the y axis. Serum response was considered
significant when above the red dotted cutoff line,
using the Mann-Whitney U test. Serum response
was determined as the ratio of the population
of cells with bound sera antibodies to the
population of transfected cells (transfection effi-
ciency). It is expressed as a percentage illustrated
as follows: serum response = (cell population with
bound sera antibodies/cell population that is
transfected) 3 100%.infection. In the future, genetically modified parasites that either
lack the NF54varsporo var gene or express genetically modified
extracellular PfEMP1 domains may help to elucidate the function
of NF54_SpzPfEMP1 during the various mosquito stages and,
perhaps, even hepatocyte infection.
Our work is highly relevant to vaccine development based on
live-attenuated sporozoites. Sterile protection in human volun-
teers has been reported after challenge with homologous, labo-
ratory-adapted P. falciparum sporozoites (Kublin et al., 2017).
Given our discovery that a clonally variant antigen on the surface
of sporozoites is expressed in a strain-specific manner, one may
speculate that natural protective immune responses target
variant sporozoite surface antigens such as PfEMP1. This could
impact the efficacy of a sporozoite vaccine in patients fromdistinct geographic regions, as has been recently reported
(Schats et al., 2015). It is noteworthy that PfEMP1 does not exist
in rodent models that are often used for sporozoite vaccine eval-
uation. Thus, prediction of vaccine efficacy in thesemodels does
not take into account the expression of P. falciparum species-
specific variant molecules.
In conclusion, this study provides evidence for the sporozoite-
specific repurposing of the PfEMP1 surface antigen family, the
biological function of which was thought to be restricted to im-
mune evasion (antigenic variation) during chronic blood stage
infection in the human host. Our discovery of a strain-specific
surface antigen may provide a molecular explanation for the
reduced protection of human volunteers after challengewith het-
erologous P. falciparum sporozoites. As our data demonstrateCell Reports 22, 2951–2963, March 13, 2018 2959
an unprecedented role of PfEMP1 proteins in transmission
stages and provide insight into the biology of sporozoites during
infection of hepatocytes, this work is highly relevant for vaccine
design based on sporozoites.
EXPERIMENTAL PROCEDURES
Human Plasma Samples
Samples were obtained from a previous clinical trial carried out at the
Radboud University Nijmegen Medical Center (Nijmegen, the Netherlands),
in accordance with principles of good clinical practice and with prior approval
from the Central Committee for Research Involving Human Subjects of the
Netherlands (NCT00442377). Study subjects (n = 14) were exposed to either
infective (n = 9) or non-infective (n = 5) mosquito bites with concurrent chloro-
quine prophylaxis (Roestenberg et al., 2009).
Isolation and Purification of P. falciparum Sporozoites and Oocysts
Adult Anopheles stephensi females were infected with either P. falciparum
strain NF54 (originating from West Africa) or strain NF135, clone C10
(originating from Cambodia) as previously described (Ponnudurai et al.,
1989; Teirlinck et al., 2013). For each biological replicate, sporozoites were
obtained by aseptically dissecting salivary glands of 200–400 infectedmosqui-
toes 14–21 days after an infective blood meal. Pooled salivary glands were
homogenized, filtered with a 40-mm cell strainer, and purified on a 17%
Accudenz gradient as previously described (Kennedy et al., 2012). For each
biological replicate, oocysts were isolated by dissection of the midguts of 50
infected mosquitoes, with an average of 45 oocysts per mosquito, 8 days
post-infection. Biological replicates came from independent rounds of
mosquito infection.
ChIP and Next-Generation Sequencing
ChIP was performed as previously described (Lopez-Rubio et al., 2009), using
5 3 106 P. falciparum sporozoites (strain NF54) or 109 asexual ring stage par-
asites (strain 3D7, clone G7). For each ChIP experiment, 0.5 mg anti-H3K9me3
(Millipore #07-442), anti-H3K9ac (Millipore #07-352), or anti-PfHP1 (Chen
et al., 2016) rabbit polyclonal antibodies was used. To generate Illumina-
compatible sequencing libraries, the immunoprecipitated DNAwas processed
using theMicroPlex Library Preparation Kit (Diagenode) according to the man-
ufacturer’s instructions. As a control, DNA corresponding to the ChIP input or
DNA immunoprecipitated using rabbit IgG (Diagenode, #C15410206) was pro-
cessed. Pooled, multiplexed libraries were subjected to 150-bp single-end
sequencing on an Illumina NextSeq 500. The resulting data were demulti-
plexed using bcl2fastq2 (Illumina) to obtain fastq files for downstream analysis.
A minimum of three biological replicates was analyzed for each antibody and
each parasite stage (Table S6).
ChIP-Seq Data Analysis
Quality control of fastq files was performed using the FastQC software
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Sequencing
reads were mapped to the P. falciparum genome (Gardner et al., 2002; Plas-
moDB, v.3) with the Burrows-Wheeler Alignment tool (BWA-MEM algorithm)
using default parameters (Li and Durbin, 2009). Uniquely mapped reads were
filtered for duplicates and an alignment quality Phred score (Q)R 20 using
samtools (Li et al., 2009). The ChIP-seq data were normalized over input.
Peak-calling analysis was performed with the MACS2 software (Zhang
et al., 2008) with default settings and a false discovery rate cutoff of 5%,
using Benjamini and Hochberg’s correction method. For genome-wide rep-
resentation of PfHP1, H3K9ac, and H3K9me3 distribution, the coverage of
each chromatin mark was calculated as average reads per million over
bins of 1,000 nt using bamCoverage from the package deepTools2 (Ramı´rez
et al., 2016), unless otherwise specified. Correlation of the different biological
replicates was determined using MACS2, bedtools (Quinlan and Hall,
2010), and deepTools2. Circular and linear coverage plots were generated
using Circos (Krzywinski et al., 2009) and Integrated Genomics Viewer
(Thorvaldsdo´ttir et al., 2013), respectively.2960 Cell Reports 22, 2951–2963, March 13, 2018RNA-Seq Library Preparation and Data Analysis
For RNA-seq library preparation, total RNA from sporozoites, oocysts,
or asexual ring stage parasites was extracted using the miRNeasy Mini Kit
(QIAGEN) according to the manufacturer’s instructions, including on-column
DNase digestion. Total RNA was poly(A)-enriched using the Dynabeads
mRNA Purification Kit (Life Technologies) and subjected to strand-specific
RNA-seq library preparation using the TruSeq Stranded mRNA Library Prep
Kit (Illumina). The libraries were multiplexed and subjected to 150-bp single-
end sequencing on an Illumina NextSeq 500. The resulting data were demulti-
plexed using bcl2fastq2 (Illumina) to obtain fastq files for downstream analysis.
A minimum of two biological replicates was analyzed for each parasite stage
(Table S6).
As described earlier, quality control of fastq files was performed using
FastQC software and sequencing reads mapped to the P. falciparum genome
(Gardner et al., 2002, PlasmoDB, v.3) with the Burrows-Wheeler Alignment tool
(BWA-MEM algorithm) using default parameters. Gene counts (i.e., the num-
ber of aligned reads mapping to different genomic loci) were calculated using
bedtools (Quinlan and Hall, 2010). Differential gene expression analysis was
performed using the R package edgeR (Robinson et al., 2010).
Multidimensional scaling (MDS) plots were also made in edgeR using
‘‘plotMDS,’’ where distances between pairs of RNA samples correspond to
the leading log2 fold changes (i.e., average [root-mean-square] of the largest
absolute log2 fold changes) (Robinson et al., 2010). To generate coverage
plots, the gene counts normalized for gene length and sequencing depth by
calculating RPKM values in the R:limma package (Ritchie et al., 2015).
Coverage plots were visualized using the Integrated Genomics Viewer
(Robinson et al., 2011; Thorvaldsdo´ttir et al., 2013).
DNA Fluorescence In Situ Hybridization and Immunofluorescence
Imaging
Sporozoites were fixed in suspension with 4% paraformaldehyde (PFA) in PBS
(pH 7.4) overnight at 4C. After three PBS washes, parasites were resus-
pended in PBS, and deposited on poly-L-lysine-coated #1.5 coverslips
(Marienfeld Superior). Parasites were permeabilized with 0.1% Triton X-100
for 15 min and subjected to DNA FISH labeling with the TARE6 probe as
described previously for blood stage parasites (Mancio-Silva et al., 2008).
Immunofluorescent labeling using rabbit anti-PfHP1 antibodies was per-
formed as previously described (Chen et al., 2016). For combined DNA FISH
and immunofluorescence, sporozoites were first labeled with rabbit anti-
PfHP1 antibodies (diluted 1:2,000 in 3% BSA [Sigma] in PBS) and then with
anti-rabbit Alexa Fluor 488 secondary antibodies (Life Technologies). After
an additional fixation step with 4% PFA, DNA FISH was performed using a
biotinylated locked nucleic acid (LNA) probe (Exiqon) targeting all TARE6
telomeric repeats (50-Biotin-+AC+T+AACA+TA+GG+T+CT+T+A-Biotin-30 ),
which was then detected with streptavidin-conjugated Alexa Fluor 568
secondary antibodies (Life Technologies).
NF54_SpzPfEMP1 Protein Expression and Antibody Generation
The DNA sequence encoding the CIDR-alpha of PF3D7_0809100 was
cloned into the Baculovirus transfer vector pAcGP67-A (BD Biosciences).
Recombinant CIDR product was expressed by infection of insect High Five
cells with recombinant Baculovirus. Antibodies to Baculo-expressed CIDR
were raised in Wistar rats by subcutaneous injection as previously described
(Bengtsson et al., 2013). All experimental animal procedures were approved
by The Danish Animal Procedures Committee (‘‘Dyreforsøgstilsynet’’) as
described in permit no. 2008/561-1498 and according to the guidelines
described in Danish acts LBK 1306 (23/11/2007) and BEK 1273 (12/12/
2005). For the mouse, anti-NF54_SpzPfEMP1 antibody production, a codon-
optimized synthetic gene encoding amino acids 1–737 of PF3D7_0809100
was synthesized by GenScript Biotech and cloned into the pET28 vector.
Recombinant protein was produced using SHuffle T7 Express bacteria (New
England BioLabs), and soluble protein was purified using Ni-NTA His Bind
Superflow Resin (Novagen) according to manufacturer’s instructions. Purified
protein (10 mg of >90% purity) was used to immunize C57BL/6 mice. Animal
care and experiments involving mice were conducted at the Institute Pasteur
with the approval of the Direction De´partementale des Services Ve´te´rinaires
of Paris, France (permit no. 75-066, issued on September 14, 2009) and
performed in compliance with institutional guidelines and European
regulations (http://ec.europa.eu/environment/chemicals/lab_animals/index_en.
htm). A statement of compliance with the French government’s ethical and an-
imal experiment regulations was issued by the Ministe`re de l’Enseignement
Supe´rieur et de la Recherche under the number 00218.01.
Western Blot Analysis
5 3 106 P. falciparum NF54 sporozoites were resuspended in 100 mL 23
NuPAGE sample buffer supplemented with reducing agent (Thermo Fisher
Scientific) and incubated at 95C for 5 min, after which DNA was sheared.
The resulting sporozoite protein extract was resolved on a 3%–8% Tris-
Acetate SDS-polyacrylamide gel (NuPAGE) using MOPS SDS Running Buffer
(Thermo Fisher Scientific) and transferred to a PVDF membrane. The mem-
brane was blocked for 1 hr with 5% milk in TBST (50 mM Tris, 150 mM
NaCl, 0.1% Tween 20). PfEMP1 proteins were detected using guinea pig
anti-ATS antibodies (Nacer et al., 2015) or anti-NF54_SpzPfEMP1 antibodies.
PfAldolase was detected with anti-PfAldolase-HRP (horseradish peroxidase)
antibodies (Abcam, ab38905). Primary antibodies were detected by goat
anti-guinea pig-HRP (Abcam, ab6908), anti-rat-HRP, or anti-mouse-HRP
(GE Healthcare Life Sciences, NA935V and NA931V, respectively) secondary
antibodies. HRP signal was developedwith SuperSignalWest Pico chemilumi-
nescent substrate (Thermo Fisher Scientific, #34080) and imaged with a
ChemiDoc XRS+ System (Bio-Rad). Images were analyzed using the Fiji image
processing package (http://fiji.sc).
Immunofluorescence Assay
NF54 or NF135 sporozoites were placed on poly-L-lysine-coated coverslips for
10minat roomtemperature (RT) underoneof threeconditions: liveor fixed in4%
PFA and permeabilized with 0.01% Triton X-100. The cells were blocked with
4% BSA in PBS for 30 min at RT and then incubated with primary antibody for
1 hr at RT; dilutions were 1:1,000 for anti-ATS, 1:1,000 for anti-
NF54_SpzPfEMP1, 1:200 for anti-var2CSA (Avril et al., 2011), and 1:15,000 for
anti-CSP (Okitsu et al., 2007) antibodies in 3% BSA in PBS. After three washes
with PBS, primary antibodies were detected with Alexa Fluor 488- or 568-
conjugated secondary antibodies (Life Technologies) diluted 1:1,000 in 3%
BSA in PBS. After three final washes in PBS, cells were mounted in
Vectashield containing DAPI for nuclear staining. Images were captured using
aDeltavision Elite imaging system (GEHealthcare). Image processing of at least
two independent replicates was performed using the Fiji package (http://fiji.sc).
For trypsinization prior to imaging, 106 living sporozoites were treated with
trypsin (GIBCO, 50 mg/mL in 200 mL Leibovitz’s L-15 medium) for 40 min at
RT. Sporozoites were then washed three times with Leibovitz’s L-15 medium
containing serumandprocessedasdescribedearlier,withall incubationson ice.
Liver Stage Development Inhibition Assay
Primary human hepatocyte cultures were prepared from two different batches
of human hepatocytes following the manufacturer’s instructions. Briefly, cryo-
preserved human hepatocytes (Biopredic International) were thawed and re-
suspended in seeding medium according to the manufacturer’s instructions.
Cells were seeded in 96-well plates previously coated with rat tail collagen I
(BD Biosciences), and after cell attachment, a Matrigel (BD Biosciences) over-
lay was added. 24 hr after plating, medium was replaced with culture medium
(William’s medium E, Life Technologies) supplemented with 10% fetal calf
serum (FCS; Perbio), 53 105 M hydrocortisone hemisuccinate (Upjohn Lab-
oratories SERB, Paris, France), 5 mg/mL human insulin (Sigma), 2 mM L-gluta-
mine, 100 U/mL penicillin, and 100 mg/mL streptomycin (Life Technologies).
The heat-inactivated mouse sera containing anti-NF54_SpzPfEMP1 anti-
bodies (diluted 1:100, 1:500, or 1:1000), the correspondent pre-immune sera
(diluted 1:100), or the purified anti-NF54_SpzPfEMP1 IgG (diluted 1:100)
were added to 50 mL medium containing 3 3 104 P. falciparum NF54 or
NF135 sporozoites. The Matrigel overlay was removed from the infected hu-
man hepatocyte culture before addition of the mixture of antibodies and spo-
rozoites. Plates were centrifuged at 2,000 rpm for 10 min at RT to facilitate
parasite settling onto the cells. Medium was changed 3 hr post-infection,
and Matrigel was added to the infected culture; medium was replaced 48 hr
post-addition of sporozoites. Cultures were stopped at day 3 post-infection
by fixing with cold methanol. Parasite numbers within hepatocytes were as-sessed via immunofluorescence using anti-PfHSP70 antibodies as previously
described (Re´nia et al., 1990). Quantification was performed by microscopy or
by using the ArrayScan XTI imaging system (Thermo Fisher Scientific).
Determination of Serum Response against NF54_SpzPfEMP1
Sera isolated from individuals from a previous clinical trial (Roestenberg et al.,
2009) were used to probeHEK293 cells transfected for cell-surface expression
of P. falciparum proteins. For NF54_SpzPfEMP1, a DNA construct encoding
amino acids 1–737 was used for transfection. These HEK293 cells were
analyzed by flow cytometry, as previously described (Peng et al., 2016). Serum
response was defined as the percentage of transfected cells that show bound
serum antibodies (Peng et al., 2016). For sera with positive serum response
(>5%), the serum response against var-transfected cells was compared with
the serum response against Etramp14.2-transfected cells (negative control),
using the Mann Whitney U test, and was found to be significantly higher.
Parasite Panning on Antibody-Coated Magnetic Beads
Sterile Dynabeads Protein G (Life Technologies 10003D) were incubated with
20 mg filtered anti-NF54_SpzPfEMP1 IgG for 10 min at RT under agitation. The
Dynabeads were blocked with 1% BSA for 20 min. iRBCs containing tropho-
zoites and schizonts were isolated by plasmagel enrichment and resuspended
in 400 mL PBS at a concentration of 53 107 iRBCs per milliliter. The iRBCs and
the beads were mixed by gently pipetting and allowed to bind for 1 hr with
gentle agitation at 37C. After incubation, the beads were washed 8 times
with 800 mL sterile PBS to eliminate all unbound cells. Bound cells were resus-
pended with culture medium and fresh red blood cells. In total, three antibody
pannings were performed. The enrichment was assessed after each panning
by IFA using anti-NF54_SpzPfEMP1.
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